icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria
Back grey_arrow_rt.gif
 
 
 
REAL-WORLD SAFETY, EFFECTIVENESS, AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION TREATED WITH GLECAPREVIR/PIBRENTASVIR: DATA FROM THE GERMAN HEPATITIS C-REGISTRY
 
 
  Reported by Jules Levin
EASL 2019 April 10-14 Vienna
 
Markus Cornberg1, Albrecht Stoehr2, Uwe Naumann3, Hartwig Klinker4, Thomas Lutz5, Willibold Schiffelholz6, NazifaQurishi7, Andreas Pangerl8,Kristina Lohmann8, Bettina Koenig8, Karl-Georg Simon9
1MedizinischeHochschule Hannover, KlinikfürGastroenterologie, Hepatologieund Endokrinologie, Hannover, Germany; 2. IFIStudienund ProjekteGmbH, Hamburg, Germany; 3. UBN-Praxis, Berlin, Germany; 4. University Hospital Würzburg, Würzburg, Germany; 5. Infektiologikum, Frankfurt, Germany; 6. GastroenterologischeSchwerpunktpraxis, Augsburg, Germany; 7. GemeinschaftspraxisGotenring, Cologne, Germany; 8. AbbVie Inc., North Chicago, Illinois, USA; 9. MVZDresEisenbach/Simon/ Schwarz/GbR, Leverkusen, Germany

0412191

0412192

0412193

0412194

0412195

0412196

0412197

0412198

0412199

04121910

04121911